Yuemin Li
No. 17, Heishanhu Road
Haidian, China
Haidian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing.
Journal: Therapeutic advances in medical oncology
Published: April 09, 2023
Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population.
Journal: Cancer biology & medicine
Published: January 11, 2022
Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer.
Journal: Materials today. Bio
Published: October 24, 2021
The pan-cancer noninvasive screening and early detection by epigenetic techniques.
Journal: Epigenomics
Published: April 20, 2021
Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM.
Journal: Frontiers in oncology
Published: October 06, 2020
The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility.
Journal: Translational lung cancer research
Published: July 18, 2020
Opportunistic screening and survival prediction of digestive cancers by the combination of blood mSEPT9 with protein markers.
Journal: Therapeutic advances in medical oncology
Published: December 31, 2019
The mSHOX2 is capable of assessing the therapeutic effect and predicting the prognosis of stage IV lung cancer.
Journal: Journal of thoracic disease
Published: August 03, 2019
Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.
Journal: Scientific reports
Published: May 13, 2019
Progress on the clinical application of the SEPT9 gene methylation assay in the past 5 years.
Journal: Biomarkers in medicine
Published: June 16, 2017
Last Updated: 09/26/2026